Wir verwenden standardmäßig essenzielle Cookies (Anmeldung, deine gespeicherten Ziele/Stacks). Mit deiner Erlaubnis aktivieren wir außerdem datenschutzfreundliche Analytik (Vercel Web Analytics, anonyme Ladezeit-Metriken) und Fehler-Replay-Diagnostik (Sentry — DOM-Snapshots nur, wenn ein Fehler auftritt), damit wir Bugs schneller beheben können. Mehr über Cookies erfahren
Ka6.0
Kava – Forschung
Hilft vermutlich
68 begutachtete Studien
Was die Evidenz sagt
Hilft vermutlich
Kava half in etwa der Hälfte (4/7) der Studien, die einen Effekt gemessen haben — vielversprechend, aber nicht einhellig.
Die meiste Evidenz stammt aus hochwertigen Meta-Analysen und randomisierten Studien, veröffentlicht 2000–2026 mit einer typischen Studiengröße von 210 Teilnehmenden.
Basierend auf 68 Studien · 10 Meta-Analysen · 33 RCTs · 5,906 Teilnehmende insgesamt
Konfidenz
Hohe Konfidenz
Was die Studien gefunden haben
4geholfen2unklar1nicht geholfen· 61 weitere ohne bewertete Effektdaten
17 Studien in den letzten 5 Jahren · Neueste Meta-Analyse: 2022
200020132026
1Systematische Übersichtn=1,020 · large study2020
Einfach gesagt: Psychotherapy seems indicated for mildly symptomatic adjustment disorder.
Constantin D et al. · American journal of therapeutics (2020)
Psychotherapy seems indicated for mildly symptomatic adjustment disorder.
Given the fact that adjustment disorder with severe symptoms is associated with a high risk of suicidal ideation and suicide attempts, clinicians must consider the potential benefit of using psychotropic agents such as benzodiazepines, antidepressants, or etifoxine.
2Clinical efficacy measures for insomniaMeta-Analysen=1,602 · large study2015
Einfach gesagt: There was no statistically significant difference between any herbal medicine and placebo, or any herbal medicine and active control, for any of the thirteen measures of clinical efficacy.
Leach MJ et al. · Sleep medicine reviews (2015)
Kein klarer Effekt
← SchlechterKein EffektBesser →
There was no statistically significant difference between any herbal medicine and placebo, or any herbal medicine and active control, for any of the thirteen measures of clinical efficacy.
As for safety, a similar or smaller number of adverse events per person were reported with kava, chamomile and wuling when compared with placebo.
By contrast, a greater number of events per person were reported with valerian.
Einfach gesagt: Existing guidelines are generally limited in providing clear, evidence-informed recommendations for the use of CAM therapies for insomnia management due to a lack of high-quality evidence and multidisciplinary consultation in CPG development.
Zhao FY et al. · Frontiers in public health (2023)
The reporting rate of eligible CPGs ranged from 42.9 to 97.1%.
Existing guidelines are generally limited in providing clear, evidence-informed recommendations for the use of CAM therapies for insomnia management due to a lack of high-quality evidence and multidisciplinary consultation in CPG development.
More well-designed studies to provide reliable clinical evidence are therefore urgently needed.
9Anxiety scores (HAMA)Meta-Analysen=29 · very small study2022
Einfach gesagt: Medicinal herbs may be promising for the treatment of anxiety.
Zhang W et al. · Pharmacological research (2022)
Spürbar Nutzen
← SchlechterKein EffektBesser →
Kava was found to be an effective anxiolytic (MD: -2.46, 95% CrI: -4.47 to -0.32) but possibly ineffective in patients with generalized anxiety disorder (MD: -0.17, 95% CrI: -2.55 to -1.97).
Ginkgo biloba (MD: -4.63, 95% CrI: -9.01 to -0.23) and Withania somnifera (MD: -4.90, 95% CrI: -9.70 to -0.17) were efficacious, as measured by HAMA scores but the trials were limited by their small sample sizes.
Conversely, although Passionflower (MD: -4.20, 95% CrI: -8.82 to 0.16) and Saffron (MD: -2.71, 95% CrI: -6.06 to 0.57) did not reduce HAMA scores significantly in the summary network, both were worthy of further study because of support from separate networks.
Einfach gesagt: Based on the current data and clinician input, a range of nutraceuticals and phytoceuticals were given either a supportive recommendation or a provisional recommendation across a range of various psychiatric disorders.
Sarris J et al. · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry (2022)
Based on the current data and clinician input, a range of nutraceuticals and phytoceuticals were given either a supportive recommendation or a provisional recommendation across a range of various psychiatric disorders.
However several had only a weak endorsement for potential use; for a few it was not possible to reach a clear recommendation direction, largely due to mixed study findings; while some other agents showed no obvious therapeutic benefit and were clearly not recommended for use.
It is the intention of these guidelines to inform psychiatric/medical, and health professional practice globally.
Einfach gesagt: Current evidence, although promising, is insufficient to confirm the effect of Kava for GAD treatment beyond placebo.
Ooi SL et al. · Journal of alternative and complementary medicine (New York, N.Y.) (2018)
Groß Nutzen
← SchlechterKein EffektBesser →
Meta-analyses of the results of three placebo-controlled trials (n = 130) favored Kava for GAD treatment with effect sizes between 0.59 and 0.99 (standard mean difference) without reaching statistical significance.
Current evidence, although promising, is insufficient to confirm the effect of Kava for GAD treatment beyond placebo.
New evidence is expected from a large, multisite ongoing trial.
Einfach gesagt: Collectively, the literature reveals preclinical and clinical evidence for various phytomedicines modulating GABA-pathways, with comparative anxiolytic effect to the current array of pharmaceuticals, along with good safety and tolerability profiles.
Savage K et al. · Phytotherapy research : PTR (2018)
An open-ended search to 5 July 2017 was conducted using MEDLINE (PubMed), Scopus, and Cochrane library online databases and performed in a stepped format from preclinical to clinical investigations.
Eligible studies must have had (a) in vitro evidence of GABA-modulating activity, (b) animal studies using anxiety models to test an anxiolytic effect, and (c) human clinical trials.
Ten phytomedicines were identified as having preclinical investigations showing interaction with the GABA system, in addition to human clinical trials: kava, valerian, pennywort, hops, chamomile, Ginkgo biloba, passionflower, ashwagandha, skullcap, and lemon balm.
Einfach gesagt: Aside from this, future focus should involve the incorporation of more biomarker analysis, in particular pharmacogenomics, to determine genetic factors moderating response to herbal medicines.
Sarris J · Phytotherapy research : PTR (2018)
Other encouraging herbal medicines with preliminary evidence include Curcuma longa (turmeric) in depression, Withania somnifera (ashwagandha) in affective disorders, and Ginkgo biloba (ginkgo) as an adjunctive treatment in Schizophrenia.
Although depression and anxiety are commonly researched, many other mental disorders still require further prospective investigation.
Although the previous review suggested increasing the adjunctive study of select herbal medicines with pharmaceuticals, this was still only found to sparingly occur in research designs.
14Anxiety and anxiety-related conditionsSystematische Übersichtn=2,619 · very large study2010
Einfach gesagt: Based on the available evidence, it appears that nutritional and herbal supplementation is an effective method for treating anxiety and anxiety-related conditions without the risk of serious side effects.
Lakhan SE et al. · Nutrition journal (2010)
Sehr groß Nutzen
← SchlechterKein EffektBesser →
Of the randomized controlled trials reviewed, 71% (15 out of 21) showed a positive direction of evidence.
Based on the available evidence, it appears that nutritional and herbal supplementation is an effective method for treating anxiety and anxiety-related conditions without the risk of serious side effects.
There is the possibility that any positive effects seen could be due to a placebo effect, which may have a significant psychological impact on participants with mental disorders.
18ADHD symptom improvementSystematische Übersichtn=16 · very small study2011
Einfach gesagt: The research suggests only some CAMs may be beneficial in ADHD, thus clinicians need to be aware of the current evidence.
Sarris J et al. · Complementary therapies in medicine (2011)
The research suggests only some CAMs may be beneficial in ADHD, thus clinicians need to be aware of the current evidence.
Promising candidates for future research include Bacopa monniera (brahmi) and Piper methysticum (kava), providing potential efficacy in improving attentional and hyperkinetic disorders via a combination of cognitive enhancing and sedative effects.